Fig. 6From: KRAS mutation in secondary malignant histiocytosis arising from low grade follicular lymphomaExome sequencing performed on the Langerhans cell sarcoma sample revealed a G13D mutation results in an amino acid substitution at position 13 in KRAS, from a glycine to an aspartic acid (Variant allele frequency: 0.24) (b). This KRAS p.G13D mutation was not present in the previous follicular lymphoma (a)Back to article page